Can Regenerative Medicine Help Knee Osteoarthritis?
“Regenerative medicine” has become one of the most talked-about—and sometimes most misunderstood—areas of musculoskeletal healthcare.
Patients come into the office having seen advertisements promising:
“Regrow your cartilage.”
“Reverse arthritis.”
“Avoid knee replacement.”
“Stem cells will rebuild your knee.”
Those statements can sound very appealing to someone who is hurting.
But patients deserve something better than promises.
They deserve an explanation.
The first thing to understand is:
Regenerative medicine is not one treatment.
It is a broad term used to describe very different biologic approaches.
These treatments do not all contain the same things.
They do not all have the same research.
They do not all have the same FDA regulatory status.
And they should not all be described as “stem cells.”
So before asking:
“Does regenerative medicine work?”
we need to ask:
“Which treatment are we talking about?”
Not Sure Where to Start?
Choose the question that sounds most like yours:
🦵 My knees hurt as I’m getting older → What Causes Knee Pain as We Get Older?
🦴 I’ve been diagnosed with osteoarthritis → What Is Knee Osteoarthritis—and Why Does It Hurt?
🩻 They told me I’m bone-on-bone → Does Bone-on-Bone Knee Arthritis Always Mean I Need a Knee Replacement?
🩸 I’m considering PRP → What Is PRP, and How Is It Used for Joint Pain?
💉 I’m deciding between PRP and cortisone → PRP vs. Cortisone Injections for Knee Pain: What’s the Difference?
🧬 I keep hearing about regenerative medicine → You’re in the right place. Keep reading.
🏥 I’m wondering whether I need surgery → When Should I Consider Knee Replacement?
What You’ll Learn
In this chapter you’ll discover:
- What “regenerative medicine” actually means
- Why the term can be confusing
- What orthobiologics are
- How PRP differs from stem-cell products
- What Wharton’s Jelly is
- What umbilical-cord-derived products are
- What amniotic products are
- What exosomes are
- Why FDA regulatory status matters
- What evidence supports PRP for knee osteoarthritis
- Whether regenerative treatments can regrow cartilage
- Why “bone-on-bone” arthritis requires realistic expectations
- How to recognize exaggerated marketing claims
- What questions to ask before receiving a biologic injection
- When conventional treatment or knee replacement may make more sense
Quick Answer
Some biologic treatments may help selected patients with knee osteoarthritis, particularly by improving pain and function.
PRP—platelet-rich plasma—has been studied extensively for knee osteoarthritis. The American Academy of Orthopaedic Surgeons states that PRP may reduce pain and improve function in patients with symptomatic knee osteoarthritis, although its recommendation remains limited because studies and PRP preparations vary considerably. AAOS also notes that evidence has not established cartilage structural improvement from PRP.
But many products marketed under the umbrella of “regenerative medicine” are very different from PRP.
The FDA specifically states that products marketed as stem-cell, Wharton’s Jelly, umbilical-cord, amniotic-fluid, and exosome therapies have not been FDA-approved for orthopedic conditions such as osteoarthritis or knee pain.
Therefore:
Never judge a treatment simply because someone calls it regenerative.
Ask exactly what the product is, what evidence supports it, what its regulatory status is, and what it can realistically be expected to accomplish.
What Does “Regenerative Medicine” Mean?
In its broadest sense, regenerative medicine refers to approaches intended to influence:
- Tissue repair
- Healing
- Biological signaling
- Restoration of function
- The body’s response to injury or disease
In orthopedics, you may also hear the term:
Orthobiologics
This generally refers to biologically derived materials used in an attempt to influence healing or musculoskeletal tissue function.
But these terms cover very different things.
Why Is the Terminology So Confusing?
Because the word:
“Regenerative”
sounds like an outcome.
A patient may reasonably think:
“If it’s regenerative medicine, it must regenerate my joint.”
That isn’t necessarily true.
A treatment can have biological activity without rebuilding an entire damaged joint.
A treatment can improve symptoms without restoring cartilage.
A treatment can be biologically interesting without yet having strong clinical evidence for a particular disease.
That’s why terminology matters.
PRP Is Not the Same as a Stem-Cell Product
PRP stands for:
Platelet-Rich Plasma
It is prepared from the patient’s own blood.
The blood is processed to produce a plasma fraction containing concentrated platelets.
PRP contains:
- Platelets
- Plasma
- Platelet-associated signaling molecules
- Various growth factors
PRP should not be described as:
Stem-cell therapy
They are not the same thing.
What Does the Research Say About PRP?
PRP is one of the better-studied orthobiologic treatments for knee osteoarthritis.
Clinical studies have found improvements in pain and patient-reported outcomes in some people with knee osteoarthritis.
But there are important limitations.
PRP preparations vary substantially.
Studies use different:
- Platelet concentrations
- White-blood-cell concentrations
- Injection schedules
- Processing systems
- Patient populations
- Arthritis severities
AAOS therefore currently describes the evidence supporting PRP for symptomatic knee osteoarthritis as limited, while acknowledging that PRP may reduce pain and improve function.
That’s a much more responsible statement than:
“PRP works for everybody.”
Does PRP Regrow Cartilage?
This is one of the biggest areas of misunderstanding.
PRP should not be promised to:
- Regrow all missing cartilage
- Restore a severely arthritic joint to normal
- Reverse bone-on-bone osteoarthritis
- Guarantee avoidance of knee replacement
AAOS’s review of PRP research found patient-reported improvements in areas such as pain and stiffness, but it did not find evidence of cartilage structural improvement in the study that evaluated that question.
That distinction is extremely important.
Feeling better is meaningful—but feeling better is not proof that cartilage has grown back.
Then Why Consider PRP?
Because improving symptoms and function matters.
Suppose after treatment you can:
- Walk farther
- Use stairs more comfortably
- Exercise more
- Sleep better
- Participate in activities you had stopped doing
That can be a meaningful clinical result.
A treatment doesn’t have to make your X-ray look 25 years younger to improve your quality of life.
What Are “Stem Cells”?
Stem cells are cells with particular abilities to:
- Self-renew
- Develop into certain other cell types under appropriate conditions
There is tremendous scientific interest in stem-cell biology.
There are also legitimate FDA-approved stem-cell products used in medicine.
But this is where patients need to understand a very important distinction.
The FDA states that the stem-cell products currently approved in the United States are blood-forming stem cells derived from umbilical-cord blood for disorders affecting blood production.
They are not approved as treatments for knee osteoarthritis or other orthopedic conditions.
What About “Stem Cell Injections” for Knees?
If a clinic tells you it is injecting:
“Stem cells into your knee”
ask:
What exactly is the product?
Where did it come from?
What cells are actually present?
Is it FDA-approved for knee osteoarthritis?
What evidence supports this exact product?
Is this being used as part of an FDA-authorized clinical trial?
Those are reasonable questions.
What Is Wharton’s Jelly?
Wharton’s Jelly is connective tissue found within the umbilical cord.
Products derived from Wharton’s Jelly have been marketed for various musculoskeletal conditions.
You may hear these products described using terms such as:
- Regenerative tissue
- Umbilical-cord tissue
- Cellular therapy
- Stem-cell therapy
- Orthobiologic treatment
But those terms should not be assumed to mean the same thing.
The FDA specifically includes Wharton’s Jelly among regenerative medicine products consumers should understand carefully and states that these products have not been FDA-approved to treat orthopedic conditions such as osteoarthritis or knee pain.
That regulatory distinction matters.
What About Umbilical-Cord Products?
Umbilical-cord-derived products are also marketed in regenerative medicine.
Again, patients need to ask:
- Is this cord blood or cord tissue?
- What exactly does the product contain?
- Is it being marketed as containing living stem cells?
- What is its regulatory status?
- What evidence supports its use for my condition?
The fact that something comes from an umbilical cord does not automatically mean it is an FDA-approved stem-cell treatment for arthritis.
What About Amniotic Products?
Products derived from placental or amniotic tissues have also been marketed for musculoskeletal conditions.
These products vary in:
- Processing
- Composition
- Intended use
- Regulatory classification
They should not automatically be called:
“Stem-cell injections.”
And their use for knee osteoarthritis should not automatically be described as FDA-approved regenerative treatment.
What Are Exosomes?
Exosomes are tiny extracellular structures involved in communication between cells.
They are an exciting area of biomedical research.
But exciting research and approved clinical treatment are not the same thing.
The FDA states that there are currently no FDA-approved exosome products.
Be especially cautious when exosomes are marketed with claims such as:
- Regrow cartilage
- Reverse arthritis
- Rejuvenate joints
- Cure degenerative disease
Those claims require strong evidence.
Why Does FDA Approval Matter?
FDA approval isn’t the only question worth asking about medical care.
But it is an important one.
Approval generally requires evidence regarding:
- Safety
- Effectiveness
- Manufacturing
- Quality
- Intended use
When a biologic product is marketed for a disease it has not been approved to treat, patients deserve to understand that clearly.
“Available” does not automatically mean “FDA-approved for your condition.”
Does “Not FDA-Approved” Automatically Mean a Treatment Is Worthless?
No.
Medicine is more nuanced than that.
Some medical treatments and medications are legitimately used off-label based on scientific evidence and clinical judgment.
But biologic products can raise additional regulatory and manufacturing questions.
The key is transparency.
Patients should know:
- What the treatment is
- Whether it is approved for the proposed use
- What evidence exists
- What risks are known
- What remains uncertain
Why Are Biologic Products Different From PRP?
PRP is prepared from the patient’s own blood at the time of treatment.
Products derived from:
- Umbilical cord
- Wharton’s Jelly
- Amniotic tissue
- Donor cells
come from another biological source and may involve:
- Donor screening
- Tissue processing
- Manufacturing
- Storage
- Distribution
- Regulatory requirements
That makes it inappropriate to place all these treatments into one bucket and simply call them:
“Regenerative injections.”
What Does “Autologous” Mean?
Autologous means:
From your own body
PRP is an example because it is prepared from your own blood.
Other procedures may use tissue taken from the patient’s:
- Bone marrow
- Fat
These procedures are different from donor-derived products.
Again:
The source matters.
What About Bone-Marrow-Based Procedures?
Bone marrow contains a mixture of:
- Blood cells
- Platelets
- Various progenitor cells
- Other biological components
Bone-marrow-derived preparations have been studied for musculoskeletal conditions.
But they should not automatically be described as proven cartilage-regeneration treatments.
The evidence, processing method, regulatory considerations, and clinical indication all matter.
What About Fat-Derived Cell Procedures?
Adipose—or fat—tissue also contains different cell populations.
Some treatments process fat tissue in an attempt to obtain cell-containing preparations.
These procedures have their own:
- Evidence
- Risks
- Processing considerations
- Regulatory requirements
They should not simply be grouped together with PRP.
Can Regenerative Medicine Reverse Osteoarthritis?
This is where I want patients to be especially careful.
Osteoarthritis involves changes in:
- Cartilage
- Bone
- Synovium
- Menisci
- Ligaments
- Muscles
- Joint mechanics
The more advanced the arthritis, the more difficult it becomes to imagine any injection completely restoring that complex joint to its original condition.
At this time:
Patients should be very skeptical of anyone guaranteeing that an injection will reverse advanced knee osteoarthritis.
What About Bone-on-Bone Arthritis?
If you have advanced bone-on-bone osteoarthritis, expectations become particularly important.
A biologic treatment may potentially improve symptoms in some patients.
But it should not be promised to:
- Restore the knee to normal
- Correct major deformity
- Restore all lost cartilage
- Reopen the joint space
- Guarantee avoidance of knee replacement
At some point, joint replacement may offer a more predictable treatment for severe structural disease and major functional loss.
Does That Mean There Is No Reason to Consider Nonsurgical Care?
Not at all.
There is a tremendous difference between:
“This treatment cannot make your knee brand new.”
and:
“There is nothing worth doing.”
Depending on the patient, nonsurgical treatment may still improve:
- Pain
- Strength
- Walking
- Activity tolerance
- Sleep
- Confidence
- Quality of life
That matters.
Where Does Exercise Fit?
Exercise remains one of the foundational treatments for knee osteoarthritis.
Appropriately selected exercise may improve:
- Strength
- Function
- Mobility
- Balance
- General health
AAOS continues to recommend exercise as part of nonsurgical knee osteoarthritis management.
No biologic injection should make us forget the importance of:
Movement and muscle.
Why Strength Matters Even If You Receive an Injection
Suppose an injection reduces your pain.
That’s great.
But if your quadriceps remain extremely weak, you may still struggle with:
- Stairs
- Standing from chairs
- Walking
- Balance
An injection doesn’t automatically rebuild lost muscle.
That’s why treatment should often include attention to function.
What About Weight Management?
For patients carrying excess weight, weight management may reduce joint loading and improve symptoms.
But weight is only one part of the picture.
Knee osteoarthritis occurs in people of every body type.
The conversation should be supportive and individualized—not judgmental.
What About Bracing?
Selected patients—particularly those with arthritis concentrated in one compartment—may benefit from an appropriately chosen brace.
Bracing may help modify how forces pass through the knee.
Again:
Sometimes the best treatment isn’t the most technologically impressive one.
What About Cortisone?
Corticosteroid injections may provide short-term symptom relief for some patients.
They don’t regenerate cartilage.
But that doesn’t make them useless.
For the right patient and the right goal, temporary relief can be valuable.
What About Knee Replacement?
Knee replacement should not be presented as the enemy of regenerative medicine.
For appropriately selected patients with:
- Advanced osteoarthritis
- Severe pain
- Major functional loss
- Significant deformity
- Failure of reasonable nonsurgical care
knee replacement can be an excellent treatment.
Good healthcare isn’t about keeping every patient away from surgery.
It’s about helping patients avoid unnecessary surgery while recognizing when surgery may be the most appropriate option.
What Are the Risks of Unapproved Regenerative Products?
This is another reason patients should ask questions.
The FDA has reported safety concerns associated with unapproved regenerative medicine products, including serious infections and other significant adverse events.
Potential risk depends on:
- Product
- Source
- Processing
- Sterility
- Route of administration
- Patient health
- Procedure
“No surgery” does not mean “no risk.”
How Can I Recognize Questionable Marketing?
Be cautious when you see claims such as:
“Guaranteed cartilage regrowth”
“100% success”
“FDA-approved stem cells for arthritis”
“Avoid knee replacement forever”
“Regrow your joint naturally”
“One injection cures bone-on-bone arthritis”
Ask for evidence.
Ask for the exact product.
Ask for its FDA status.
Ask what outcomes were actually studied.
What Questions Should I Ask a Regenerative Medicine Clinic?
Before receiving a biologic treatment, ask:
- What exactly are you injecting?
- Where does it come from?
- Is it from my own body or a donor?
- Does it actually contain living cells?
- Are you calling it a stem-cell treatment? If so, why?
- Is it FDA-approved for knee osteoarthritis?
- If it isn’t approved, what is its regulatory status?
- What clinical evidence supports this exact treatment for my condition?
- What are the risks?
- What can it realistically accomplish?
- What can it not accomplish?
- What alternatives do I have?
- What happens if it doesn’t work?
- When would you recommend that I see an orthopedic surgeon?
A provider offering the treatment should be comfortable answering those questions.
Don’t Be Afraid to Ask About FDA Status
Patients sometimes feel uncomfortable asking:
“Is this FDA-approved?”
Don’t.
That’s a completely reasonable question.
And the answer should not be evasive.
A good healthcare conversation should make complicated information clearer—not harder to understand.
How We Approach Regenerative Medicine at Advanced Integrated Medical
At Advanced Integrated Medical, I believe the conversation should begin with:
Diagnosis—not the injection.
Before discussing a biologic treatment, I want to understand:
- What is causing the pain?
- Where is the arthritis?
- How advanced is it?
- What does the imaging show?
- How strong is the patient?
- How well does the joint move?
- How well does the patient walk?
- What treatments have already been tried?
- What medical conditions are present?
- What medications are being taken?
- What does the patient hope to accomplish?
Then we can discuss which options deserve consideration.
Treatment Depends on the Cause, Severity, and Goal
A 55-year-old with moderate osteoarthritis who wants to remain active may have very different options from an 82-year-old with:
- Severe bone-on-bone arthritis
- Major deformity
- Significant loss of motion
- Severe night pain
- Major walking limitations
The diagnosis may be:
Knee osteoarthritis
for both patients.
But the appropriate treatment may be very different.
The treatment should fit the patient—not the marketing category.
About Dr. Dee
Dr. D. Scott (“Dee”) Stevens has spent nearly four decades helping patients with joint disorders, musculoskeletal injuries, sports injuries, chronic pain, peripheral neuropathy, and regenerative medicine.
Throughout his career, he has cared for patients from all walks of life—including professional, collegiate, and Olympic athletes, professional football players, Major League Baseball players, professional boxers, and MMA fighters.
I’ve watched many new treatments come into healthcare over the years.
Some have become extremely valuable.
Some haven’t lived up to their early promises.
That experience has taught me something important:
Never fall in love with the treatment before you understand the patient.
Dr. Dee’s Clinical Pearl
Whenever someone tells you:
“This will regenerate your joint,”
ask one more question:
“How do you know?”
What was measured?
Pain?
Function?
MRI?
Cartilage thickness?
Joint-space width?
Surgery avoidance?
Those aren’t the same outcomes.
A patient feeling better is valuable.
But don’t call pain improvement:
“Cartilage regeneration”
unless there is reliable evidence demonstrating cartilage regeneration.
Dr. Dee’s Office Conversation
Patient: “Doctor, is this a stem-cell injection?”
Dr. Dee: “Before we call it anything, let’s identify exactly what’s in it.”
Patient: “Does that really matter?”
Dr. Dee: “Absolutely. PRP, bone-marrow preparations, Wharton’s Jelly products, umbilical-cord products, amniotic products, and exosomes are not interchangeable.”
Patient: “But they’re all called regenerative medicine.”
Dr. Dee: “That’s why the label isn’t enough. You deserve to know exactly what you’re receiving.”
Facing One of the Biggest Fears
“If Regenerative Medicine Can’t Guarantee New Cartilage, Does That Mean I’m Out of Options?”
No.
This is where realistic hope matters.
The goal may not be:
“Make my 70-year-old knee look like it did when I was 20.”
The goal may be:
- Reduce pain
- Walk farther
- Improve strength
- Use stairs
- Sleep better
- Stay active
- Delay surgery when appropriate
- Maintain independence
- Improve quality of life
And if surgery ultimately becomes the best option, that doesn’t mean the nonsurgical journey failed.
Joint Health Success Principle #6
Know Exactly What You’re Receiving
Never be satisfied with:
“It’s regenerative.”
Ask:
What is it?
Where did it come from?
What’s actually in it?
What evidence supports it?
What is its FDA status?
What is it supposed to accomplish?
What are the risks?
What are the alternatives?
An informed patient should know more than the name on the brochure.
Ask Dr. Dee
“Doctor, does regenerative medicine really work?”
My first response would be:
“Which regenerative treatment?”
That’s the point.
PRP has evidence supporting potential improvement in pain and function for selected patients with knee osteoarthritis, although the evidence and protocols have limitations.
Other products marketed under the regenerative medicine umbrella have different evidence and different regulatory status.
So I don’t think it’s medically useful to say:
“Regenerative medicine works.”
or:
“Regenerative medicine doesn’t work.”
We have to identify the actual treatment.
Lesson I’ve Learned in Nearly 40 Years
New Doesn’t Mean Bad—and New Doesn’t Mean Proven
Medicine advances because people are willing to investigate new ideas.
We should never close the door on innovation.
But we shouldn’t confuse enthusiasm with evidence either.
I’ve learned to ask:
What do we know?
What don’t we know yet?
What are we hoping to accomplish?
What are the risks?
What are the alternatives?
And:
“What would I want someone to explain to me if this were my knee?”
Patients deserve that level of honesty.
The Hope Principle
There are two ways to take hope away from a patient.
One is to say:
“There’s nothing you can do.”
The other is to give them false hope through promises that cannot be supported.
Neither is good medicine.
Realistic hope says:
Let’s understand your knee.
Let’s understand your options.
Let’s identify what we can reasonably improve.
Let’s protect your function.
Let’s use nonsurgical care when it makes sense.
And let’s recognize surgery when surgery becomes the better choice.
Hope doesn’t need a miracle claim. Hope needs an honest next step.
“I believe the best healthcare decisions are made when patients understand their condition. My job isn’t simply to treat symptoms—it’s to help you understand why they’re happening and what your options are.”
— Dr. D. Scott (“Dee”) Stevens
Frequently Asked Questions
What is regenerative medicine?
Regenerative medicine is a broad term covering different biological approaches intended to influence tissue repair, healing, or function. It is not one specific treatment.
Is PRP regenerative medicine?
PRP is commonly grouped within regenerative medicine or orthobiologics. It is prepared from the patient’s own blood and is different from stem-cell or donor-tissue products.
Is PRP a stem-cell treatment?
No. PRP is primarily a platelet- and plasma-based preparation.
Can PRP help knee osteoarthritis?
AAOS states that PRP may reduce pain and improve function in patients with symptomatic knee osteoarthritis, although the strength of the recommendation is limited because the evidence and preparations are heterogeneous.
Does PRP regrow knee cartilage?
PRP should not be promised to restore an advanced arthritic knee to normal. AAOS’s review found no evidence of cartilage structural improvement in the study evaluating that outcome.
Are Wharton’s Jelly products FDA-approved for knee osteoarthritis?
No. The FDA states that Wharton’s Jelly and other regenerative medicine products it identifies have not been approved for orthopedic conditions such as osteoarthritis or knee pain.
Are umbilical-cord stem cells FDA-approved for arthritis?
No. FDA-approved cord-blood stem-cell products are approved for certain blood-forming disorders, not knee osteoarthritis.
Are exosomes FDA-approved for knee arthritis?
No. The FDA states that there are currently no FDA-approved exosome products.
Can regenerative medicine prevent knee replacement?
No biologic treatment should be guaranteed to prevent future knee replacement.
Can biologic injections help bone-on-bone arthritis?
Some treatments may improve symptoms in selected patients, but advanced structural arthritis generally produces less predictable nonsurgical outcomes. Major deformity or severe functional loss may make orthopedic surgical consultation more appropriate.
Is knee replacement better than regenerative medicine?
They are not equivalent treatments. The appropriate choice depends on arthritis severity, symptoms, function, health, previous treatment, and patient goals.
Key Takeaways
- Regenerative medicine is a broad term—not one treatment.
- PRP is different from stem-cell, Wharton’s Jelly, umbilical-cord, amniotic, and exosome products.
- PRP is prepared from the patient’s own blood.
- Evidence suggests PRP may improve pain and function for some patients with knee osteoarthritis, although evidence remains heterogeneous.
- PRP should not be promised to regrow an advanced arthritic joint.
- Wharton’s Jelly, umbilical-cord, amniotic, and exosome products should not be represented as FDA-approved treatments for knee osteoarthritis.
- There are currently no FDA-approved exosome products.
- FDA-approved cord-blood stem-cell products are used for certain blood-forming disorders—not orthopedic arthritis treatment.
- “Biologically active” does not automatically mean “proven to regenerate cartilage.”
- Symptom improvement does not prove structural regeneration.
- Exercise, strength, weight management when appropriate, bracing, and conventional treatments remain important.
- Knee replacement can be an excellent treatment when appropriately indicated.
- Be cautious of guarantees.
- Ask exactly what is being injected.
- Hope should be based on understanding—not hype.
Why Patients Choose Advanced Integrated Medical
At Advanced Integrated Medical, we believe patients considering regenerative medicine deserve more than:
“Trust us—this will regenerate your knee.”
They deserve to understand:
What is the diagnosis?
What does the X-ray show?
How advanced is the arthritis?
What exactly is the treatment?
Where does it come from?
What evidence supports it?
What is its regulatory status?
What can it realistically accomplish?
What are its limitations?
What are the alternatives?
And:
“Is this actually the right treatment for me?”
The goal isn’t to sell a treatment because it sounds advanced.
The goal is to help the patient make an informed decision.
Continue Exploring the Joint Pain & Regenerative Medicine Learning Center
You may also want to read:
- What Causes Knee Pain as We Get Older?
- What Is Knee Osteoarthritis—and Why Does It Hurt?
- Does Bone-on-Bone Knee Arthritis Always Mean I Need a Knee Replacement?
- What Is PRP, and How Is It Used for Joint Pain?
- PRP vs. Cortisone Injections for Knee Pain: What’s the Difference?
- Why Does My Knee Hurt Going Up and Down Stairs?
- Why Does My Knee Hurt on the Inside? Understanding Medial Knee Pain
- When Should I Consider Knee Replacement?
- What Should a Good Knee Pain Evaluation Include?
Medical Disclaimer
This article is intended for educational purposes only and is not a substitute for individualized medical diagnosis, treatment, or regulatory advice.
“Regenerative medicine” encompasses many different products and procedures with different evidence, risks, manufacturing methods, and regulatory classifications. Patients should understand exactly what product or procedure is being proposed.
The FDA states that regenerative medicine products including products marketed as stem-cell, Wharton’s Jelly, umbilical-cord, amniotic-fluid, and exosome therapies have not been approved for treatment of orthopedic conditions such as osteoarthritis or knee pain. FDA-approved cord-blood stem-cell products are approved for certain disorders of the blood-forming system, not for orthopedic arthritis treatment.
PRP is a different type of autologous blood-derived treatment. Evidence suggests it may improve pain and function for selected patients with knee osteoarthritis, but it should not be considered a guaranteed cure or guaranteed cartilage-regeneration procedure.
All injections and procedures have potential risks. Treatment decisions should consider diagnosis, medical history, medications, examination findings, imaging, arthritis severity, current evidence, regulatory status, alternatives, and individual goals.
Ready to Learn More?
If you’re considering something described as:
“Regenerative medicine,”
don’t stop with the name.
Ask:
What exactly is being injected?
Is it PRP?
Is it from my own body?
Is it donor tissue?
Is someone calling it a stem-cell treatment?
What evidence supports it for knee osteoarthritis?
What is its FDA regulatory status?
What can it realistically accomplish?
What can it not accomplish?
What are my alternatives?
When might surgery be the better choice?
At Advanced Integrated Medical, we believe innovation and honesty should go together.
Patients should have hope.
But that hope should be based on a clear understanding of the treatment—not simply an impressive name.
Know what you’re receiving. Know what the evidence says. Know what the treatment can realistically do. Then make an informed decision.
Advanced Integrated Medical
Advanced Care • Natural Healing • Real Results